AbbVie Cash on Hand 2010-2024 | ABBV | MacroTrends

AbbVie Cash on Hand 2010-2024 | ABBV

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AbbVie cash on hand for the quarter ending June 30, 2024 was $13.157B, a 50.09% increase year-over-year.

AbbVie cash on hand for 2023 was $12.816B, a 38.87% increase from 2022.
AbbVie cash on hand for 2022 was $9.229B, a 6.11% decline from 2021.
AbbVie cash on hand for 2021 was $9.83B, a 15.93% increase from 2020.

AbbVie Cash on Hand 2010-2024 | ABBV

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AbbVie cash on hand for 2023 was $12.816B, a 38.87% increase from 2022.
AbbVie cash on hand for 2022 was $9.229B, a 6.11% decline from 2021.
AbbVie cash on hand for 2021 was $9.83B, a 15.93% increase from 2020.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$861.3B
Novo Nordisk (NVO)	$592.4B
Johnson & Johnson (JNJ)	$402.2B
Merck (MRK)	$299.6B
AstraZeneca (AZN)	$243.5B
Novartis AG (NVS)	$236.5B
Pfizer (PFE)	$169B
Sanofi (SNY)	$144.1B
Innoviva (INVA)	$1.2B